Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spironolactone vs Doxycycline for Acne in Women
NCT04582383Phase 4Active, not recruiting
- Sponsor
- University of Pennsylvania
- Start
- Mar 2022
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of spironolactone in acne vulgaris, sponsored by University of Pennsylvania. Started Mar 2022; status: active, not recruiting.
02
Drugs
spironolactone
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT04582383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04582383.